Skip to main content
SpringerLink
Log in

Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme

  • Clinical Trials Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yung WK, Prados MD, Yaya-Tur R, et al.: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 1999, 17:2762–2771.

    PubMed  CAS  Google Scholar 

  2. Yung WK, Albright RE, Olson J, et al.: A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 2000, 83:588–593.

    Article  PubMed  CAS  Google Scholar 

  3. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al.: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002, 20:1375–1382.

    Article  PubMed  CAS  Google Scholar 

  4. Fine HA, Dear KB, Loeffler JS, et al.: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993, 71:2585–2597.

    Article  PubMed  CAS  Google Scholar 

  5. Mirimanoff R, Mason W, Kortmann R, et al.: Radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus radiotherapy alone for newly diagnosed glioblastoma (GBM): overall results and recursive partitioning analysis (RPA) of a phase iii randomized trial of the EORTC brain tumor and radiotherapy groups and the NCIC clinical trial group [abstract]. Int J Radiat Oncol Biol Physiol 2004, 60(Suppl 1):S162.

    Article  Google Scholar 

  6. Hegi M, Diserens A, Gorlia T, et al.: MGMT gene silencing and benefit from temozolomide in glioblastoma. emozolomide (TMZ)targets only glioblastoma. N Engl J Med 2005, 352:997–1003.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Lauren E. Abrey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abrey, L.E. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme. Curr Neurol Neurosci Rep 5, 167–168 (2005). https://doi.org/10.1007/s11910-005-0043-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-005-0043-y

Keywords

Search

Navigation